Tilray Brands, Inc.
General ticker "TLRY" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $921.5M (TTM average)
Tilray Brands, Inc. follows the US Stock Market performance with the rate: 40.5%.
Estimated limits based on current volatility of 5.5%: low 7.50$, high 8.37$
Factors to consider:
- Total employees count: 2650 (+65.6%) as of 2024
- US accounted for 29.6% of revenue in the fiscal year ended 2024-05-31
- Top business risk factors: Regulatory and compliance, Market competition, Litigation risks, Customer dependency, Cybersecurity threats
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-05-31 to 2026-05-31
- 2024-05-31 to 2025-05-31 estimated range: [11.03$, 21.69$]
- 2025-05-31 to 2026-05-31 estimated range: [9.28$, 18.70$]
Financial Metrics affecting the TLRY estimates:
- Positive: with PPE of -5.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.24 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Investing cash flow per share per price, % of 9.29 > -0.66
- Positive: Industry inventory ratio change (median), % of -0.91 <= -0.15
Short-term TLRY quotes
Long-term TLRY plot with estimates
Financial data
| YTD | 2024-05-31 |
|---|---|
| Operating Revenue | $1,074.99MM |
| Operating Expenses | $1,313.09MM |
| Operating Income | $-238.10MM |
| Non-Operating Income | $-101.20MM |
| Interest Expense | $67.13MM |
| R&D Expense | $0.87MM |
| Income(Loss) | $-339.31MM |
| Taxes | $-36.27MM |
| Profit(Loss)* | $-333.80MM |
| Stockholders Equity | $3,442.91MM |
| Inventory | $343.49MM |
| Assets | $4,221.66MM |
| Operating Cash Flow | $-30.91MM |
| Capital expenditure | $39.85MM |
| Investing Cash Flow | $128.35MM |
| Financing Cash Flow | $-75.19MM |
| Earnings Per Share** | $-4.49 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.